Dominic Piscitelli
Director of Finance/CFO at ORIC PHARMACEUTICALS, INC.
Net worth: 642 815 $ as of 2024-04-29
Dominic Piscitelli active positions
Companies | Position | Start | End |
---|---|---|---|
ORIC PHARMACEUTICALS, INC. | Director of Finance/CFO | 2019-08-31 | - |
Public Communications Contact | - | - | |
CELYAD ONCOLOGY SA | Director/Board Member | 2020-05-05 | - |
Independent Dir/Board Member | 2020-05-05 | - |
Career history of Dominic Piscitelli
Former positions of Dominic Piscitelli
Companies | Position | Start | End |
---|---|---|---|
ANAPTYSBIO, INC. | Director of Finance/CFO | 2017-01-10 | 2019-08-15 |
Investor Relations Contact | 2017-01-10 | 2019-08-15 | |
MEDIVATION INC | Director of Finance/CFO | 2012-08-31 | 2016-12-31 |
Investor Relations Contact | 2012-08-31 | 2016-12-31 | |
Astellas Pharmaceuticals SA | Corporate Officer/Principal | 2011-08-31 | 2012-08-31 |
OSI PHARMACEUTICALS, INC. | Corporate Officer/Principal | - | - |
Treasurer | 2008-12-31 | 2010-12-31 |
Training of Dominic Piscitelli
Hofstra University | Masters Business Admin |
Statistics
International
United States | 6 |
Belgium | 2 |
Greece | 2 |
Operational
Director of Finance/CFO | 3 |
Investor Relations Contact | 2 |
Corporate Officer/Principal | 2 |
Sectoral
Health Technology | 6 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 3 |
---|---|
ANAPTYSBIO, INC. | Health Technology |
CELYAD ONCOLOGY SA | Health Technology |
ORIC PHARMACEUTICALS, INC. | Health Technology |
Private companies | 3 |
---|---|
OSI Pharmaceuticals, Inc.
OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OSI Pharmaceuticals, Inc. manufactured and develope dpharmaceutical drugs. The company was founded in 1983 and was headquartered in Farmingdale, NY. | Health Technology |
Medivation LLC (California)
Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Medivation LLC engages in the development and commercialization of novel therapies to treat serious diseases for which there are limited treatment options. The company was founded by Clarence Patrick Machado and David T. Hung in 2004 and is headquartered in San Francisco, CA. | Health Technology |
Astellas Pharmaceuticals SA |
- Stock Market
- Insiders
- Dominic Piscitelli
- Experience